Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Plakhins, Grigorijs ^a,b   Irmejs, Arvids ^a,b   Gardovskis, Andris ^a,b   Subatniece, Signe ^a   Rozite, Santa ^c   Bitina, Marianna ^d   Keire, Guntars ^e   Purkalne, Gunta ^b   Teibe, Uldis ^a   Trofimovics, Genadijs ^a,b   Miklasevics, Edvins ^a   Gardovskis, Janis ^a,b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^c Ministry of Health of the Republic of Latvia   (Latvia)

^d Daugavpils Regional Hospital   (Latvia)

^e Oncology Clinic   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; LATVIA; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; AGED; BREAST TUMOR; FOUNDER EFFECT; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; ONSET AGE; OVARY TUMOR; STATISTICS; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENETIC ASSOCIATION STUDIES; HUMANS; LATVIA; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; OVARIAN NEOPLASMS; PREVALENCE; SEQUENCE DELETION; YOUNG ADULT;

EID: 80054960784     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-147     Document Type: Article

References (24)

1. Tan DS, Marchiò C, Reis-Filho JS. Hereditary breast cancer: from molecular pathology to tailored therapies. J Clin Pathol 2008, 61(10):1073-1082. 10.1136/jcp.2008.057950, 18682420.
2. Ramus SJ, Gayther SA. The Contribution of BRCA1 and BRCA2 to Ovarian Cancer. Mol Oncol 2009, 3(2):138-150. 10.1016/j.molonc.2009.02.001, 19383375.
3. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol 2010, 4(3):174-191. 10.1016/j.molonc.2010.04.011, 20542480.
4. Hohenstein P, Fodde R. Of mice and (wo)men: genotype-phenotype correlations in BRCA1. Hum Mol Genet 2003, 12(Spec No 2):R271-7.
5. Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Division 2008, 3:1. 10.1186/1747-1028-3-1, 2254412, 18179693.
6. Thompson D, Easton D, . Breast Cancer Linkage Consortium Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 2002, 11(4):329-336. Breast Cancer Linkage Consortium.
7. Vanags A, Strumfa I, Gardovskis A, et al. Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hered Cancer Clin Pract 2010, 8(1):8. 10.1186/1897-4287-8-8, 2978132, 21034437.
8. Tikhomirova L, Sinicka O, Smite D, Eglitis J, Hodgson SV, Stengrevics A. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Familial Cancer 2005, 4(2):77-84. 10.1007/s10689-004-2758-3, 15951956.
9. Gardovskis A, Irmejs A, Miklasevics E, et al. Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia. Hered Cancer Clin Pract 2005, 3(2):71-76. 10.1186/1897-4287-3-2-71, 2837301, 20223033.
10. Gronwald J, Elsakov P, Górski B, Lubiński J. High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat 2005, 94(2):111-113. 10.1007/s10549-005-5150-6, 16261409.
11. Gorski B, Byrski T, Huzarski T, et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 2000, 66:1963-1968. 10.1086/302922, 1378051, 10788334.
12. Elsakov P, Kurtinaitis J, Petraitis S, et al. The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania. Clin Genet 2010, 78(4):373-376. 10.1111/j.1399-0004.2010.01404.x, 20345474.
13. Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Hillemanns P, Dörk T. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus. Clin Genet 2010, 78(4):364-372. 10.1111/j.1399-0004.2010.01473.x, 20569256.
14. Menkiszak J, Gronwald J, Górski B, et al. Hereditary ovarian cancer in Poland. Int J Cancer 2003, 106(6):942-945. 10.1002/ijc.11338, 12918074.
15. Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA. A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet 2004, 41(12):e130. 10.1136/jmg.2004.019430, 1735637, 15591272.
16. Satagopan JM, Boyd J, Kauff ND, et al. Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations. Clin Cancer Res 2002, 8(12):3776-3781.
17. Al-Mulla F, Bland JM, Serratt D, Miller J, Chu C, Taylor GT. Age-dependent penetrance of different germline mutations in the BRCA1 gene. J Clin Pathol 2009, 62(4):350-356. 10.1136/jcp.2008.062646, 2656651, 19329713.
18. Cortesi L, Masini C, Cirilli C, et al. Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. BMC Cancer 2010, 10:90. 10.1186/1471-2407-10-90, 2847959, 20219108.
19. Robson ME, Chappuis PO, Satagopan J, et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 2004, 6(1):R8-R17. 10.1186/bcr658, 314444, 14680495.
20. Rennert G, Bisland-Naggan S, Barnett-Griness O, et al. Clinical Outcomes of Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations. N Engl J Med 2007, 357(2):115-123. 10.1056/NEJMoa070608, 17625123.
21. Rebbeck TR, Friebel T, Lynch HT. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group. J Clin Oncol 2004, 22(6):1055-1062. 10.1200/JCO.2004.04.188, 14981104.
22. Hartmann LC, Sellers TA, Schaid DJ. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001, 93(21):1633-1637. 10.1093/jnci/93.21.1633, 11698567.
23. Matloff ET, Barnett RE, Bober SL. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers. Cancer J 2009, 15(1):15-18. 10.1097/PPO.0b013e31819585f1, 19197168.
24. Shulman LP. Hereditary Breast and Ovarian Cancer (HBOC): Clinical Features and Counseling for BRCA1 and BRCA2, Lynch Syndrome, Cowden Syndrome, and Li-Fraumeni Syndrome. Obstet Gynecol Clin North Am 2010, 37(1):109-133. 10.1016/j.ogc.2010.03.003, 20494261.